I’ve been stuck on the disconnect between metabolic substrate availability and the immunosenescence profile. We know BHB acts as an endogenous HDAC inhibitor, specifically targeting HDAC1/3 and driving hyperacetylation at the Foxo3a and Mt2 promoters. But what if this isn't just a homeostatic signal? What if it's actually a fundamental switch for T-cell persistence?

Usually, we frame T-cell exhaustion—whether in TILs or chronic stimulation models—as a signaling breakdown, dominated by PD-1/LAG-3 or transcriptional repression via TOX. Maybe we’ve got that backward. What if the failure to sustain histone β-hydroxybutyrylation (Kbhb), a direct epigenetic readout of metabolic flux, is what allows the exhaustion program to settle in?

If a cell can’t maintain these non-canonical histone marks due to a depleted BHB pool, it probably loses its ability to keep metabolic and effector genes in an open chromatin state. By starving these cells of the substrates needed for epigenetic maintenance, we aren't just depriving them of fuel; we’re actively de-repressing the senescence-associated secretory phenotype (SASP) and the pathways that lead to terminal exhaustion.

I’m trying to figure out if localized BHB flux acts as a barrier to the "epigenetic drift" that characterizes immune aging. I’m not sure yet if this is a simple stoichiometric limitation or a threshold-gated signaling event. If we could force a localized ketogenic state within the T-cell compartment, could we stop the locking of exhausted states that checkpoint inhibitors only partially resolve?

Some questions keep coming up:

• Does mitochondrial efficiency dictate the sensitivity of these specific HDAC-regulated promoters?
• Are there specific histone lysines where Kbhb directly blocks the recruitment of TOX-associated co-repressors?
• Is this mechanism purely cell-intrinsic, or does it depend on systemic ketone body availability?

I’m curious if anyone has investigated the crosstalk between Kbhb-mediated chromatin occupancy and the accessibility landscape of exhausted T-cells using ATAC-seq during a metabolic shift.